Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06963203 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis

Study acronym: GRATES
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date: May 2025 to Jul 1, 2025
    • Study sites: 1 to 15
    • Collaborators: 9 to 14
    v3
  2. Study description expanded, about 3 wordsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to learn about the potential differences in morbidity of thyroidectomy (removal of the thyroid gland) depending on the preoperative hormonal status. The main question it aims to answer is: Do patients undergoing thyroidectomy for thyreotoxicosis (thyroid hyperfunction) due to Graves' disease or Amiodarone induced thyreotoxicosis have comparable complication rates depending on their thyroid metabolic status prior or during the procedure. The data from participants undergoing a thyroidectomy at one of the study sites will be prospectively registered in the EUROCRINE registry, including an add-on module for additional study specific routine data. The operation itself, the preoperative or postoperative treatments are not altered in any way.
Trial Details
NCT Number NCT06963203
Lead Sponsor Andrea Goldmann
Collaborators: Spital Männedorf, Spital Limmattal Schlieren, Centre Hospitalier Universitaire Vaudois, Ospedale Regionale di Mendrisio, Cantonal Hospital of St. Gallen, Cantonal Hosptal, Baselland, St. Claraspital AG, University Hospital, Geneva, Insel Gruppe AG, University Hospital Bern, ASZ Aalst, University Hospital Virgen de las Nieves, University of Nancy, Hospital Costa del Sol, Evgenidion Hospital Athens, Greece
Conditions
(from sponsor)		 Graves Disease, Amiodarone-Induced Thyrotoxicosis, Thyroidectomy
Related terms Graves Disease, Thyroid Crisis
Enrollment 486 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov